Use of Sodium Channel Blocker Injection in the Management of Low Back Pain as a Stop Gap During Covid Pandemic—Our Experience

Authors

  • T. Satishkumar Assistant Professor, Department of Orthopaedics, Government Stanley Medical College and Hospital, Chennai, Tamil Nadu, India
  • A Guruprasath Senior Assistant Professor, Department of Orthopaedics, Government Stanley Medical College and Hospital, Chennai, Tamil Nadu, India
  • Dr.U Venktesh Junior Resident, Department of Orthopaedics, Government Stanley Medical College and Hospital, Chennai, Tamil Nadu, India
  • Dr.T Tholgapiyan Professor and Head of the department of Orthopedics, Government Stanley Medical College and Hospital, Chennai, Tamil Nadu, India

Keywords:

DSCB, MRI, LS Spine, SCB, VAS, Lignocaine, Chennai Cocktail

Abstract

Low back is a common symptom we encounter in the out patient department. The COVID pandemic brought about new difficulties in the form of lack of operating tables and delay in surgical intervention. We explored the possibility of a new method to alleviate the pain, and which was consistent with the outcome. The sodium channel blocker injection brought about immediate pain relief and improved the quality of life in all our patients and was an essential tool that functioned as a stop gap during the COVID pandemic.

 

References

Wu N. March." Employment and Chinese Women." Beijing Review. 1995; 6: 12.

Wu, Aimin et al. “Global low back pain prevalence and years lived with disability from 1990 to 2017: estimates from the Global Burden of Disease Study 2017.” Annals of translational medicine. 2020; 8(6): 299.

Bredow J, Bloess K, Oppermann J, et al. [Conservative treatment of nonspecific, chronic low back pain: Evidence of the efficacy-a systematic literature review]. Der Orthopade. 2016; 45(7): 573-578.

Gore S, Nadkarni S. Sciatica: detection and confirmation by new method. Int J Spine Surg. 2014; 8:15.

Wu LC, Weng PW, Chen CH, et al. Literature Review and Meta-Analysis of Transcutaneous Electrical Nerve Stimulation in Treating Chronic Back Pain. Reg Anesth Pain Med. 2018; 43(4): 425-433.

Schwarm FP, Stein M, Uhl E, et al. A Retrospective Analysis of 25 Cases with Peripheral Nerve Field Stimulation for Chronic Low Back Pain and the Predictive Value of Transcutaneous Electrical Nerve Stimulation for Patient Selection. Neuromodulation. 2019; 22(5): 607-614.

Kloimstein H, Likar R, Kern M, et al. Peripheral nerve field stimulation (PNFS) in chronic low back pain: a prospective multicenter study. Neuromodulation. 2014; 17(2): 180-7.

Hamm-Faber TE, Aukes HA, de Loos F, Gültuna I. Subcutaneous stimulation as an additional therapy to spinal cord stimulation for the treatment of lower limb pain and/or back pain: a feasibility study. Neuromodulation. 2012; 15(2): 108-16.

Hamm-Faber TE, Gültuna I, van Gorp EJ, Aukes H. High-Dose Spinal Cord Stimulation for Treatment of Chronic Low Back Pain and Leg Pain in Patients with FBSS, 12-Month Results: A Prospective Pilot Study. Neuromodulation. 2020; 23(1): 118-125.

Taylor RS, Desai MJ, Rigoard P. Predictors of pain relief following spinal cord stimulation in chronic back and leg pain and failed back surgery syndrome: a systematic review and meta-regression analysis. Pain Pract. 2014; 14(6): 489-505.

Downloads

Published

2022-08-25

Issue

Vol. 11 No. 2 (2022)

Section

Case Study

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have neither given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.